From 0ec35b523b1e3c7d9b719d6ab5fe59458deb5490 Mon Sep 17 00:00:00 2001 From: c-schuler Date: Thu, 10 Nov 2022 13:51:59 -0700 Subject: [PATCH] reverted copyright back to 2016+ --- .../activitydefinition-opioidcds-risk-assessment-request.xml | 2 +- .../activitydefinition-opioidcds-urine-screening-request.xml | 2 +- input/resources/plandefinition/opioidcds-01.json | 2 +- input/resources/plandefinition/opioidcds-02.json | 2 +- input/resources/plandefinition/opioidcds-03-patient-view.json | 2 +- input/resources/plandefinition/opioidcds-03.json | 2 +- input/resources/plandefinition/opioidcds-04-05.json | 2 +- input/resources/plandefinition/opioidcds-06.json | 2 +- input/resources/plandefinition/opioidcds-07.json | 2 +- input/resources/plandefinition/opioidcds-08-order-sign.json | 2 +- input/resources/plandefinition/opioidcds-08.json | 2 +- input/resources/plandefinition/opioidcds-09.json | 2 +- input/resources/plandefinition/opioidcds-10-order-sign.json | 2 +- input/resources/plandefinition/opioidcds-10-patient-view.json | 2 +- input/resources/plandefinition/opioidcds-10.json | 2 +- input/resources/plandefinition/opioidcds-11-patient-view.json | 2 +- input/resources/plandefinition/opioidcds-11.json | 2 +- input/resources/plandefinition/opioidcds-12-patient-view.json | 2 +- .../valueset/valueset-benzodiazepine-medications.json | 2 +- .../valueset-buprenorphine-and-methadone-medications.json | 2 +- .../valueset/valueset-cdc-malignant-cancer-conditions.json | 2 +- .../valueset/valueset-cocaine-urine-drug-screening-tests.json | 2 +- .../valueset-conditions-documenting-substance-misuse.json | 2 +- ...ueset-conditions-likely-terminal-for-opioid-prescribing.json | 2 +- ...xtended-release-opioid-with-ambulatory-misuse-potential.json | 2 +- .../vocabulary/valueset/valueset-fentanyl-type-medications.json | 2 +- .../valueset-fentanyl-type-urine-drug-screening-tests.json | 2 +- .../valueset-general-opiate-urine-drug-screening-tests.json | 2 +- input/vocabulary/valueset/valueset-hospice-finding.json | 2 +- input/vocabulary/valueset/valueset-hospice-procedure.json | 2 +- .../valueset/valueset-limited-life-expectancy-conditions.json | 2 +- input/vocabulary/valueset/valueset-naloxone-medications.json | 2 +- .../valueset/valueset-non-opioid-drug-urine-screening.json | 2 +- .../valueset/valueset-non-synthetic-opioid-medications.json | 2 +- .../valueset/valueset-oncology-specialty-designations.json | 2 +- .../valueset-opiate-specific-urine-drug-screening-tests.json | 2 +- ...eset-opioid-analgesics-with-ambulatory-misuse-potential.json | 2 +- .../valueset/valueset-opioid-counseling-procedure.json | 2 +- .../valueset/valueset-opioid-drug-urine-screening.json | 2 +- .../valueset/valueset-opioid-misuse-assessment-procedure.json | 2 +- input/vocabulary/valueset/valueset-opioid-misuse-disorders.json | 2 +- .../vocabulary/valueset/valueset-pain-management-procedure.json | 2 +- input/vocabulary/valueset/valueset-pain-treatment-plan.json | 2 +- .../valueset/valueset-pdmp-data-reviewed-finding.json | 2 +- input/vocabulary/valueset/valueset-pdmp-review-procedure.json | 2 +- .../valueset-phencyclidine-urine-drug-screening-tests.json | 2 +- input/vocabulary/valueset/valueset-sickle-cell-diseases.json | 2 +- .../valueset-substance-misuse-behavioral-counseling.json | 2 +- .../valueset-synthetic-opioid-urine-drug-screening-tests.json | 2 +- .../valueset-therapies-indicating-end-of-life-care.json | 2 +- .../valueset/valueset-urine-drug-screening-tests.json | 2 +- 51 files changed, 51 insertions(+), 51 deletions(-) diff --git a/input/resources/activitydefinition/activitydefinition-opioidcds-risk-assessment-request.xml b/input/resources/activitydefinition/activitydefinition-opioidcds-risk-assessment-request.xml index 16c1cf2e..2df506da 100644 --- a/input/resources/activitydefinition/activitydefinition-opioidcds-risk-assessment-request.xml +++ b/input/resources/activitydefinition/activitydefinition-opioidcds-risk-assessment-request.xml @@ -31,7 +31,7 @@ - + diff --git a/input/resources/activitydefinition/activitydefinition-opioidcds-urine-screening-request.xml b/input/resources/activitydefinition/activitydefinition-opioidcds-urine-screening-request.xml index 89b0180b..6c1c9b96 100644 --- a/input/resources/activitydefinition/activitydefinition-opioidcds-urine-screening-request.xml +++ b/input/resources/activitydefinition/activitydefinition-opioidcds-urine-screening-request.xml @@ -31,7 +31,7 @@ - + diff --git a/input/resources/plandefinition/opioidcds-01.json b/input/resources/plandefinition/opioidcds-01.json index 2e5f85fb..ca31d476 100644 --- a/input/resources/plandefinition/opioidcds-01.json +++ b/input/resources/plandefinition/opioidcds-01.json @@ -531,7 +531,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for Subacute or Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "Clinicians should consider opioid therapy only if expected benefits for both pain and function are anticipated to outweigh risks to the patient.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/resources/plandefinition/opioidcds-02.json b/input/resources/plandefinition/opioidcds-02.json index 16081231..14a3791a 100644 --- a/input/resources/plandefinition/opioidcds-02.json +++ b/input/resources/plandefinition/opioidcds-02.json @@ -613,7 +613,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "Clinicians should continue opioid therapy only if there is clinically meaningful improvement in pain and function that outweighs risks to patient safety.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/resources/plandefinition/opioidcds-03-patient-view.json b/input/resources/plandefinition/opioidcds-03-patient-view.json index 32b6629d..7433df8a 100644 --- a/input/resources/plandefinition/opioidcds-03-patient-view.json +++ b/input/resources/plandefinition/opioidcds-03-patient-view.json @@ -622,7 +622,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for Subacute or Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "Providers should use caution when prescribing extended-release/long-acting (ER/LA) opioids as they carry a higher risk and negligible benefit compared to immediate-release opioids.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/resources/plandefinition/opioidcds-03.json b/input/resources/plandefinition/opioidcds-03.json index 6baa63f0..ce3dbcc6 100644 --- a/input/resources/plandefinition/opioidcds-03.json +++ b/input/resources/plandefinition/opioidcds-03.json @@ -598,7 +598,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for Subacute or Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "Providers should use caution when prescribing extended-release/long-acting (ER/LA) opioids as they carry a higher risk and negligible benefit compared to immediate-release opioids.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/resources/plandefinition/opioidcds-04-05.json b/input/resources/plandefinition/opioidcds-04-05.json index bc83dd51..21e8ccb5 100644 --- a/input/resources/plandefinition/opioidcds-04-05.json +++ b/input/resources/plandefinition/opioidcds-04-05.json @@ -683,7 +683,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "Providers should use caution when prescribing opioids at any dosage, should carefully reassess evidence of individual benefits and risks when considering increasing dosage to ≥50 morphine milligram equivalents (MME)/day, and should avoid increasing dosage to ≥90 MME/day or carefully justify a decision to titrate dosage to >90 MME/day", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/resources/plandefinition/opioidcds-06.json b/input/resources/plandefinition/opioidcds-06.json index 82689fb7..fa53152d 100644 --- a/input/resources/plandefinition/opioidcds-06.json +++ b/input/resources/plandefinition/opioidcds-06.json @@ -499,7 +499,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for Subacute or Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "When opioids are used for acute pain, clinicians should prescribe the lowest effective dose of immediate-release opioids and should prescribe no greater quantity than needed for the expected duration of pain severe enough to require opioids.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/resources/plandefinition/opioidcds-07.json b/input/resources/plandefinition/opioidcds-07.json index 66d9c705..1c5ac94c 100644 --- a/input/resources/plandefinition/opioidcds-07.json +++ b/input/resources/plandefinition/opioidcds-07.json @@ -716,7 +716,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for Subacute or Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "If benefits do not outweigh harms of continued opioid therapy, clinicians should optimize other therapies and work with patients to taper opioids to lower dosages or to taper and discontinue opioids.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/resources/plandefinition/opioidcds-08-order-sign.json b/input/resources/plandefinition/opioidcds-08-order-sign.json index 58f10c05..9998e588 100644 --- a/input/resources/plandefinition/opioidcds-08-order-sign.json +++ b/input/resources/plandefinition/opioidcds-08-order-sign.json @@ -823,7 +823,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "Before starting and periodically during continuation of opioid therapy, clinicians should evaluate risk factors for opioid-related harms.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/resources/plandefinition/opioidcds-08.json b/input/resources/plandefinition/opioidcds-08.json index 9eaaa7a7..19844bfb 100644 --- a/input/resources/plandefinition/opioidcds-08.json +++ b/input/resources/plandefinition/opioidcds-08.json @@ -823,7 +823,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "Before starting and periodically during continuation of opioid therapy, clinicians should evaluate risk factors for opioid-related harms.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/resources/plandefinition/opioidcds-09.json b/input/resources/plandefinition/opioidcds-09.json index 1397ad56..2e2e683d 100644 --- a/input/resources/plandefinition/opioidcds-09.json +++ b/input/resources/plandefinition/opioidcds-09.json @@ -553,7 +553,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "Clinicians should review PDMP data when starting opioid therapy for chronic pain and periodically during opioid therapy for chronic pain.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/resources/plandefinition/opioidcds-10-order-sign.json b/input/resources/plandefinition/opioidcds-10-order-sign.json index 19581286..3b7cdde8 100644 --- a/input/resources/plandefinition/opioidcds-10-order-sign.json +++ b/input/resources/plandefinition/opioidcds-10-order-sign.json @@ -770,7 +770,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for Subacute or Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "Providers should be aware if patients are taking other prescription drugs or illicit drugs that might increase their risk of an overdose.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/resources/plandefinition/opioidcds-10-patient-view.json b/input/resources/plandefinition/opioidcds-10-patient-view.json index aa73607f..f1740f16 100644 --- a/input/resources/plandefinition/opioidcds-10-patient-view.json +++ b/input/resources/plandefinition/opioidcds-10-patient-view.json @@ -794,7 +794,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for Subacute or Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "Providers should be aware if patients are taking other prescription drugs or illicit drugs that might increase their risk of an overdose.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/resources/plandefinition/opioidcds-10.json b/input/resources/plandefinition/opioidcds-10.json index bbe21f2c..ad8531ac 100644 --- a/input/resources/plandefinition/opioidcds-10.json +++ b/input/resources/plandefinition/opioidcds-10.json @@ -770,7 +770,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for subacute or Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "Providers should be aware if patients are taking other prescription drugs or illicit drugs that might increase their risk of an overdose.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/resources/plandefinition/opioidcds-11-patient-view.json b/input/resources/plandefinition/opioidcds-11-patient-view.json index 234a822b..0a7167b5 100644 --- a/input/resources/plandefinition/opioidcds-11-patient-view.json +++ b/input/resources/plandefinition/opioidcds-11-patient-view.json @@ -576,7 +576,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for Subacute or Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "Clinicians should avoid prescribing opioid pain medication and benzodiazepines or other central nervous system depressant concurrently whenever possible.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/resources/plandefinition/opioidcds-11.json b/input/resources/plandefinition/opioidcds-11.json index e22ea213..2c7ce9b1 100644 --- a/input/resources/plandefinition/opioidcds-11.json +++ b/input/resources/plandefinition/opioidcds-11.json @@ -627,7 +627,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "Clinicians should avoid prescribing opioid pain medication and benzodiazepines or other central nervous system depressant concurrently whenever possible.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/resources/plandefinition/opioidcds-12-patient-view.json b/input/resources/plandefinition/opioidcds-12-patient-view.json index 547723f0..9e21e360 100644 --- a/input/resources/plandefinition/opioidcds-12-patient-view.json +++ b/input/resources/plandefinition/opioidcds-12-patient-view.json @@ -403,7 +403,7 @@ } ], "purpose": "CDC's Guideline for Prescribing Opioids for Subacute or Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.", "usage": "Clinicians should offer or arrange evidence-based treatment (usually medication-assisted treatment with buprenorphine or methadone) for patients with opioid use disorder.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "topic": [ { "text": "Opioid Prescribing" } ], diff --git a/input/vocabulary/valueset/valueset-benzodiazepine-medications.json b/input/vocabulary/valueset/valueset-benzodiazepine-medications.json index fce39bc1..dfe09139 100644 --- a/input/vocabulary/valueset/valueset-benzodiazepine-medications.json +++ b/input/vocabulary/valueset/valueset-benzodiazepine-medications.json @@ -56,7 +56,7 @@ } ] } ], "purpose": "Benzodiazepine medications for opioid management", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "expansion": { "identifier": "6758d93c-2361-4f04-abad-40015a0d557a", "timestamp": "2022-05-09T13:03:22-06:00", diff --git a/input/vocabulary/valueset/valueset-buprenorphine-and-methadone-medications.json b/input/vocabulary/valueset/valueset-buprenorphine-and-methadone-medications.json index 14c12404..124d26a4 100644 --- a/input/vocabulary/valueset/valueset-buprenorphine-and-methadone-medications.json +++ b/input/vocabulary/valueset/valueset-buprenorphine-and-methadone-medications.json @@ -56,7 +56,7 @@ } ] } ], "purpose": "Buprenorphine and Methadone medications for opioid management", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", diff --git a/input/vocabulary/valueset/valueset-cdc-malignant-cancer-conditions.json b/input/vocabulary/valueset/valueset-cdc-malignant-cancer-conditions.json index ec3de2ff..8076ce16 100644 --- a/input/vocabulary/valueset/valueset-cdc-malignant-cancer-conditions.json +++ b/input/vocabulary/valueset/valueset-cdc-malignant-cancer-conditions.json @@ -56,7 +56,7 @@ } ] } ], "purpose": "Cancer conditions to be used as an exclusion for opioid management review", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://hl7.org/fhir/sid/icd-10-cm", diff --git a/input/vocabulary/valueset/valueset-cocaine-urine-drug-screening-tests.json b/input/vocabulary/valueset/valueset-cocaine-urine-drug-screening-tests.json index 72cce441..6e87d36f 100644 --- a/input/vocabulary/valueset/valueset-cocaine-urine-drug-screening-tests.json +++ b/input/vocabulary/valueset/valueset-cocaine-urine-drug-screening-tests.json @@ -50,7 +50,7 @@ } ] } ], "purpose": "Identification of urine drug tests where results can be used when considering pain management therapy", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "expansion": { "identifier": "13682c93-b63e-4e91-aabb-8e92ceaaf9ab", "timestamp": "2022-05-09T13:00:29-06:00", diff --git a/input/vocabulary/valueset/valueset-conditions-documenting-substance-misuse.json b/input/vocabulary/valueset/valueset-conditions-documenting-substance-misuse.json index a032cede..e571dec2 100644 --- a/input/vocabulary/valueset/valueset-conditions-documenting-substance-misuse.json +++ b/input/vocabulary/valueset/valueset-conditions-documenting-substance-misuse.json @@ -44,7 +44,7 @@ } ] } ], "purpose": "Identification of patients that have a documented substance misuse condition now or in the past when considering opioid therapy.", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://snomed.info/sct", diff --git a/input/vocabulary/valueset/valueset-conditions-likely-terminal-for-opioid-prescribing.json b/input/vocabulary/valueset/valueset-conditions-likely-terminal-for-opioid-prescribing.json index 995279a5..ae609180 100644 --- a/input/vocabulary/valueset/valueset-conditions-likely-terminal-for-opioid-prescribing.json +++ b/input/vocabulary/valueset/valueset-conditions-likely-terminal-for-opioid-prescribing.json @@ -56,7 +56,7 @@ } ] } ], "purpose": "Conditions for exclusions in CDC 2022 Opioid Guideline", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://hl7.org/fhir/sid/icd-10-cm", diff --git a/input/vocabulary/valueset/valueset-extended-release-opioid-with-ambulatory-misuse-potential.json b/input/vocabulary/valueset/valueset-extended-release-opioid-with-ambulatory-misuse-potential.json index bd18410b..f55fa17c 100644 --- a/input/vocabulary/valueset/valueset-extended-release-opioid-with-ambulatory-misuse-potential.json +++ b/input/vocabulary/valueset/valueset-extended-release-opioid-with-ambulatory-misuse-potential.json @@ -59,7 +59,7 @@ } ] } ], "purpose": "Identify medication orders for long-acting opioids", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "expansion": { "identifier": "5726ab61-d902-4519-870b-5012db6284af", "timestamp": "2022-05-09T13:00:29-06:00", diff --git a/input/vocabulary/valueset/valueset-fentanyl-type-medications.json b/input/vocabulary/valueset/valueset-fentanyl-type-medications.json index ec66a5a5..ec111afe 100644 --- a/input/vocabulary/valueset/valueset-fentanyl-type-medications.json +++ b/input/vocabulary/valueset/valueset-fentanyl-type-medications.json @@ -46,7 +46,7 @@ "code": "US" } ] } ], - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "expansion": { "identifier": "559d8b02-03c1-4f1b-9337-4d0f6caacd2a", "timestamp": "2022-05-09T13:00:29-06:00", diff --git a/input/vocabulary/valueset/valueset-fentanyl-type-urine-drug-screening-tests.json b/input/vocabulary/valueset/valueset-fentanyl-type-urine-drug-screening-tests.json index 919e3728..7e29b2c9 100644 --- a/input/vocabulary/valueset/valueset-fentanyl-type-urine-drug-screening-tests.json +++ b/input/vocabulary/valueset/valueset-fentanyl-type-urine-drug-screening-tests.json @@ -43,7 +43,7 @@ "code": "US" } ] } ], - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://loinc.org", diff --git a/input/vocabulary/valueset/valueset-general-opiate-urine-drug-screening-tests.json b/input/vocabulary/valueset/valueset-general-opiate-urine-drug-screening-tests.json index 10acf877..518de6b9 100644 --- a/input/vocabulary/valueset/valueset-general-opiate-urine-drug-screening-tests.json +++ b/input/vocabulary/valueset/valueset-general-opiate-urine-drug-screening-tests.json @@ -53,7 +53,7 @@ } ] } ], "purpose": "Identification of urine drug tests where results can be used when considering pain management therapy", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "expansion": { "identifier": "37c90ea1-de62-441d-b69f-925dd8e21817", "timestamp": "2022-05-09T13:00:29-06:00", diff --git a/input/vocabulary/valueset/valueset-hospice-finding.json b/input/vocabulary/valueset/valueset-hospice-finding.json index 719434db..2d74a930 100644 --- a/input/vocabulary/valueset/valueset-hospice-finding.json +++ b/input/vocabulary/valueset/valueset-hospice-finding.json @@ -53,7 +53,7 @@ } ] } ], "purpose": "Initially created to identify conditions for exclusions in CDC 2022 Opioid Guideline", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://snomed.info/sct", diff --git a/input/vocabulary/valueset/valueset-hospice-procedure.json b/input/vocabulary/valueset/valueset-hospice-procedure.json index bf3196a6..42fb3e6e 100644 --- a/input/vocabulary/valueset/valueset-hospice-procedure.json +++ b/input/vocabulary/valueset/valueset-hospice-procedure.json @@ -49,7 +49,7 @@ "code": "US" } ] } ], - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://snomed.info/sct", diff --git a/input/vocabulary/valueset/valueset-limited-life-expectancy-conditions.json b/input/vocabulary/valueset/valueset-limited-life-expectancy-conditions.json index 4e5ac52c..b87fc463 100644 --- a/input/vocabulary/valueset/valueset-limited-life-expectancy-conditions.json +++ b/input/vocabulary/valueset/valueset-limited-life-expectancy-conditions.json @@ -56,7 +56,7 @@ } ] } ], "purpose": "Provide terminology for conditions to be used as exclusions for opioid use recommendations", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://snomed.info/sct", diff --git a/input/vocabulary/valueset/valueset-naloxone-medications.json b/input/vocabulary/valueset/valueset-naloxone-medications.json index 22abfa55..ddb2d375 100644 --- a/input/vocabulary/valueset/valueset-naloxone-medications.json +++ b/input/vocabulary/valueset/valueset-naloxone-medications.json @@ -56,7 +56,7 @@ } ] } ], "purpose": "Naloxone medications for opioid management", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", diff --git a/input/vocabulary/valueset/valueset-non-opioid-drug-urine-screening.json b/input/vocabulary/valueset/valueset-non-opioid-drug-urine-screening.json index 3996acea..cf5c25ff 100644 --- a/input/vocabulary/valueset/valueset-non-opioid-drug-urine-screening.json +++ b/input/vocabulary/valueset/valueset-non-opioid-drug-urine-screening.json @@ -44,7 +44,7 @@ } ] } ], "purpose": "Identification of non-opioid urine drug tests where rusults can be used when considering opioid therapy", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://loinc.org", diff --git a/input/vocabulary/valueset/valueset-non-synthetic-opioid-medications.json b/input/vocabulary/valueset/valueset-non-synthetic-opioid-medications.json index 6c9bb587..9971bfff 100644 --- a/input/vocabulary/valueset/valueset-non-synthetic-opioid-medications.json +++ b/input/vocabulary/valueset/valueset-non-synthetic-opioid-medications.json @@ -46,7 +46,7 @@ "code": "US" } ] } ], - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "expansion": { "identifier": "a5f5cd26-090e-40b6-871e-242eea85be23", "timestamp": "2022-05-09T13:00:29-06:00", diff --git a/input/vocabulary/valueset/valueset-oncology-specialty-designations.json b/input/vocabulary/valueset/valueset-oncology-specialty-designations.json index 72e4566a..7c0e8ee3 100644 --- a/input/vocabulary/valueset/valueset-oncology-specialty-designations.json +++ b/input/vocabulary/valueset/valueset-oncology-specialty-designations.json @@ -56,7 +56,7 @@ } ] } ], "purpose": "Provider types used to identify cancer care related encounters", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://nucc.org/provider-taxonomy", diff --git a/input/vocabulary/valueset/valueset-opiate-specific-urine-drug-screening-tests.json b/input/vocabulary/valueset/valueset-opiate-specific-urine-drug-screening-tests.json index 2ab51f24..06f8c1bf 100644 --- a/input/vocabulary/valueset/valueset-opiate-specific-urine-drug-screening-tests.json +++ b/input/vocabulary/valueset/valueset-opiate-specific-urine-drug-screening-tests.json @@ -53,7 +53,7 @@ } ] } ], "purpose": "Identification of urine drug tests where results can be used when considering pain management therapy", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "expansion": { "identifier": "d257ac37-d2ab-4445-80b1-e06dd367f46e", "timestamp": "2022-05-09T13:00:29-06:00", diff --git a/input/vocabulary/valueset/valueset-opioid-analgesics-with-ambulatory-misuse-potential.json b/input/vocabulary/valueset/valueset-opioid-analgesics-with-ambulatory-misuse-potential.json index 831bc906..392b6f78 100644 --- a/input/vocabulary/valueset/valueset-opioid-analgesics-with-ambulatory-misuse-potential.json +++ b/input/vocabulary/valueset/valueset-opioid-analgesics-with-ambulatory-misuse-potential.json @@ -59,7 +59,7 @@ } ] } ], "purpose": "Opioid medications that should have opioid management CDS", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "expansion": { "identifier": "33bc1977-428c-44cd-9be7-c2568cbed1f9", "timestamp": "2022-05-09T13:03:22-06:00", diff --git a/input/vocabulary/valueset/valueset-opioid-counseling-procedure.json b/input/vocabulary/valueset/valueset-opioid-counseling-procedure.json index 229aeff5..4b5e6001 100644 --- a/input/vocabulary/valueset/valueset-opioid-counseling-procedure.json +++ b/input/vocabulary/valueset/valueset-opioid-counseling-procedure.json @@ -44,7 +44,7 @@ } ] } ], "purpose": "Identify a procedure for opioid use couseling to the patient", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://snomed.info/sct", diff --git a/input/vocabulary/valueset/valueset-opioid-drug-urine-screening.json b/input/vocabulary/valueset/valueset-opioid-drug-urine-screening.json index af3aa881..2af75f92 100644 --- a/input/vocabulary/valueset/valueset-opioid-drug-urine-screening.json +++ b/input/vocabulary/valueset/valueset-opioid-drug-urine-screening.json @@ -44,7 +44,7 @@ } ] } ], "purpose": "Identification of opioid urine drug tests where rusults can be used when considering opioid therapy", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://loinc.org", diff --git a/input/vocabulary/valueset/valueset-opioid-misuse-assessment-procedure.json b/input/vocabulary/valueset/valueset-opioid-misuse-assessment-procedure.json index 29ade5b6..d0a13326 100644 --- a/input/vocabulary/valueset/valueset-opioid-misuse-assessment-procedure.json +++ b/input/vocabulary/valueset/valueset-opioid-misuse-assessment-procedure.json @@ -44,7 +44,7 @@ } ] } ], "purpose": "Risk assessment to occur when considering opioid therapy", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://snomed.info/sct", diff --git a/input/vocabulary/valueset/valueset-opioid-misuse-disorders.json b/input/vocabulary/valueset/valueset-opioid-misuse-disorders.json index c9d97bfb..388bf384 100644 --- a/input/vocabulary/valueset/valueset-opioid-misuse-disorders.json +++ b/input/vocabulary/valueset/valueset-opioid-misuse-disorders.json @@ -56,7 +56,7 @@ } ] } ], "purpose": "Conditions that may indicate need for opioid management", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://snomed.info/sct", diff --git a/input/vocabulary/valueset/valueset-pain-management-procedure.json b/input/vocabulary/valueset/valueset-pain-management-procedure.json index 478f157f..2e906362 100644 --- a/input/vocabulary/valueset/valueset-pain-management-procedure.json +++ b/input/vocabulary/valueset/valueset-pain-management-procedure.json @@ -44,7 +44,7 @@ } ] } ], "purpose": "A procedure to provide chronic pain control management", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://snomed.info/sct", diff --git a/input/vocabulary/valueset/valueset-pain-treatment-plan.json b/input/vocabulary/valueset/valueset-pain-treatment-plan.json index 41d0b11b..67f87ad9 100644 --- a/input/vocabulary/valueset/valueset-pain-treatment-plan.json +++ b/input/vocabulary/valueset/valueset-pain-treatment-plan.json @@ -44,7 +44,7 @@ } ] } ], "purpose": "Identification of Pain medicine Plan of care note for use in opioid therapy management", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://loinc.org", diff --git a/input/vocabulary/valueset/valueset-pdmp-data-reviewed-finding.json b/input/vocabulary/valueset/valueset-pdmp-data-reviewed-finding.json index 1d279b89..db34150f 100644 --- a/input/vocabulary/valueset/valueset-pdmp-data-reviewed-finding.json +++ b/input/vocabulary/valueset/valueset-pdmp-data-reviewed-finding.json @@ -44,7 +44,7 @@ } ] } ], "purpose": "Finding indicating that the Prescription Drug Monitoring Program (PDMP) data was reviewed", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://snomed.info/sct", diff --git a/input/vocabulary/valueset/valueset-pdmp-review-procedure.json b/input/vocabulary/valueset/valueset-pdmp-review-procedure.json index 3ecf2ced..a12f6f59 100644 --- a/input/vocabulary/valueset/valueset-pdmp-review-procedure.json +++ b/input/vocabulary/valueset/valueset-pdmp-review-procedure.json @@ -44,7 +44,7 @@ } ] } ], "purpose": "A procedure to review the prescription drug monitoring program data", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://snomed.info/sct", diff --git a/input/vocabulary/valueset/valueset-phencyclidine-urine-drug-screening-tests.json b/input/vocabulary/valueset/valueset-phencyclidine-urine-drug-screening-tests.json index 77588a76..148878f2 100644 --- a/input/vocabulary/valueset/valueset-phencyclidine-urine-drug-screening-tests.json +++ b/input/vocabulary/valueset/valueset-phencyclidine-urine-drug-screening-tests.json @@ -56,7 +56,7 @@ } ] } ], "purpose": "Identification of urine drug tests where results can be used when considering pain management therapy", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "expansion": { "identifier": "f25f5e40-a769-41b7-94a4-c2593a6fa148", "timestamp": "2022-05-09T13:00:29-06:00", diff --git a/input/vocabulary/valueset/valueset-sickle-cell-diseases.json b/input/vocabulary/valueset/valueset-sickle-cell-diseases.json index 10f52c8c..391072af 100644 --- a/input/vocabulary/valueset/valueset-sickle-cell-diseases.json +++ b/input/vocabulary/valueset/valueset-sickle-cell-diseases.json @@ -56,7 +56,7 @@ } ] } ], "purpose": "Conditions due to Sickle-cell that can cause painful crisis to be used as exclusions for opioid use recommendations", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://snomed.info/sct", diff --git a/input/vocabulary/valueset/valueset-substance-misuse-behavioral-counseling.json b/input/vocabulary/valueset/valueset-substance-misuse-behavioral-counseling.json index e9cb346e..4cf2b330 100644 --- a/input/vocabulary/valueset/valueset-substance-misuse-behavioral-counseling.json +++ b/input/vocabulary/valueset/valueset-substance-misuse-behavioral-counseling.json @@ -56,7 +56,7 @@ } ] } ], "purpose": "Counseling and associated procedures for substance misuse that may be used for opioid management", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://snomed.info/sct", diff --git a/input/vocabulary/valueset/valueset-synthetic-opioid-urine-drug-screening-tests.json b/input/vocabulary/valueset/valueset-synthetic-opioid-urine-drug-screening-tests.json index 5c0162fb..6d15ddef 100644 --- a/input/vocabulary/valueset/valueset-synthetic-opioid-urine-drug-screening-tests.json +++ b/input/vocabulary/valueset/valueset-synthetic-opioid-urine-drug-screening-tests.json @@ -56,7 +56,7 @@ } ] } ], "purpose": "Identification of urine drug tests where results can be used when considering pain management therapy", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "valueSet": [ "http://fhir.org/guides/cdc/opioid-cds/ValueSet/opioid-drug-urine-screening" ] diff --git a/input/vocabulary/valueset/valueset-therapies-indicating-end-of-life-care.json b/input/vocabulary/valueset/valueset-therapies-indicating-end-of-life-care.json index aa6361b7..d70074ef 100644 --- a/input/vocabulary/valueset/valueset-therapies-indicating-end-of-life-care.json +++ b/input/vocabulary/valueset/valueset-therapies-indicating-end-of-life-care.json @@ -56,7 +56,7 @@ } ] } ], "purpose": "Conditions for exclusions in CDC 2022 Opioid Guideline", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "system": "http://snomed.info/sct", diff --git a/input/vocabulary/valueset/valueset-urine-drug-screening-tests.json b/input/vocabulary/valueset/valueset-urine-drug-screening-tests.json index c2a4e2a4..b481001e 100644 --- a/input/vocabulary/valueset/valueset-urine-drug-screening-tests.json +++ b/input/vocabulary/valueset/valueset-urine-drug-screening-tests.json @@ -44,7 +44,7 @@ } ] } ], "purpose": "Identification of urine drug tests where rusults can be used when considering pain management therapy", - "copyright": "© CDC 2022+.", + "copyright": "© CDC 2016+.", "compose": { "include": [ { "valueSet": [ "http://fhir.org/guides/cdc/opioid-cds/ValueSet/non-opioid-illicit-drug-urine-screening" ]